Cargando…
TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability
BACKGROUND: Metabolic reprogramming is a hallmark of various cancers. Targeting metabolic processes is a very attractive treatment for cancer. Renal cell carcinoma (RCC) is a type of metabolic disease, and the lipidomic profile of RCC is significantly altered compared with that of healthy tissue. Ho...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875457/ https://www.ncbi.nlm.nih.gov/pubmed/36694250 http://dx.doi.org/10.1186/s13046-022-02583-z |